Angelica Quartino

6PUBLICATIONS
23CO-AUTHORS
Epidemiological modellingNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2023
Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR-SB.

Samira Jamalian, Michael Dolton, Pascal Chanu

|Jan 23, 2023
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results.

Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad

|Sep 24, 2021
Correction to: Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.

Bei Wang, Rong Deng, Stefanie Hennig

|Jun 09, 2021
Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.

Bei Wang, Rong Deng, Stefanie Hennig

|May 31, 2021
Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitor.

Phyllis Chan, Han Ting Ding, Bianca M Liederer

|Jan 24, 2020
Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease.

Kenta Yoshida, Anita Moein, Tobias Bittner

Pageof 1

Frequent Collaborators

2 joint publications

Bei Wang

2 joint publications

Rong Deng

2 joint publications

Stefanie Hennig

2 joint publications

Tanja Badovinac Crnjevic